Document Detail


Vasculogenesis and angiogenesis in the IUGR placenta.
MedLine Citation:
PMID:  18482617     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Placenta vascular formation is important for fetal growth and development. Proper development of the placenta ensures the exchange of oxygen/nutrients and blood flow necessary for fetal growth. In this chapter, we will discuss the processes of vasculogenesis, angiogenesis, and pseudovasculogenesis during placental development and in pregnancies complicated by intrauterine growth restriction. Some of the factors controlling these processes include oxygen, the VEGF family of growth factors, and their receptors. Disruption in the balance of these controlling factors may explain the vascular malformations seen in pregnancies complicated by intrauterine growth restriction.
Authors:
Juan A Arroyo; Virginia D Winn
Related Documents :
15611967 - Fetal origins of developmental plasticity: are fetal cues reliable predictors of future...
3492147 - Epidermal growth factor deficiency during pregnancy causes abortion in mice.
2130837 - Effect of maternal and fetal characteristics on diagnosis of intrauterine growth retard...
778817 - Recognizing the fetus at risk.
7319947 - Synchronization of ewes during anestrus: influence of time of year and interval to onse...
6392577 - High-resolution sonographic assessment of the fetal extremities.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in perinatology     Volume:  32     ISSN:  0146-0005     ISO Abbreviation:  Semin. Perinatol.     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-05-16     Completed Date:  2008-09-30     Revised Date:  2014-05-15    
Medline Journal Info:
Nlm Unique ID:  7801132     Medline TA:  Semin Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  172-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chorionic Villi / physiology*
Female
Fetal Growth Retardation / etiology*,  physiopathology
Growth Substances / physiology
Humans
Neovascularization, Pathologic / physiopathology*
Placenta / blood supply*,  pathology
Pregnancy
Grant Support
ID/Acronym/Agency:
R01 HD060723/HD/NICHD NIH HHS; UL1 RR025780/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Growth Substances

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Non-placental causes of intrauterine growth restriction.
Next Document:  Nutrient transport across the intrauterine growth-restricted placenta.